Get the Stockscreener App
87.89
1.51%
1.31
After Hours:
87.95
0.06
+0.07%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $87.89, with a volume of 9.07M.
It is up +1.51% in the last 24 hours and down -9.06% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$86.58
Open:
$86.9
24h Volume:
9.07M
Relative Volume:
1.15
Market Cap:
$112.84B
Revenue:
$35.48B
Net Income/Loss:
$4.64B
P/E Ratio:
24.54
EPS:
3.582
Net Cash Flow:
$5.41B
1W Performance:
+0.78%
1M Performance:
-9.06%
6M Performance:
-6.80%
1Y Performance:
-0.79%
1-Day Range:
$86.34
$88.07
1-Week Range:
$85.78
$88.07
52-Week Range:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.62 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication - MedTech Dive
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain? - TradingView
Medtronic (MDT) Revises Earnings Outlook Amid MiniMed IPO Impact - GuruFocus
Medtronic lowers earnings forecast after MiniMed IPO - Yahoo Finance
Medtronic inks distribution deal for Merit Medical’s basivertebral ablation system - Medical Device Network
Medtronic cuts earnings outlook on MiniMed updates (MDT:NYSE) - Seeking Alpha
Medtronic (MDT) Announces FDA Approval for Expanded Indication of OmniaSecure - Insider Monkey
Medtronic plc stock faces pressure amid cardiovascular device scrutiny and slowing growth in Q1 2026 - AD HOC NEWS
Medtronic plc Files Form 8-K Disclosing Senior Notes and Company Information (March 24, 2026) - Minichart
Medtronic plc stock faces pressure after cutting fiscal 2026 guidance on $157 million one-time charg - AD HOC NEWS
Medtronic cuts annual forecast on $157 million one-time charge - marketscreener.com
Medtronic (MDT) Adjusts EPS Forecast Following MiniMed Developme - GuruFocus
Medtronic Cuts Fiscal 2026 EPS Outlook After MiniMed Charges - TipRanks
Medtronic (MDT) cuts FY26 EPS outlook as MiniMed Flex funding and IPO dilute earnings - Stock Titan
Medtronic to distribute Merit Medical’s low back pain treatment - MedTech Dive
Medtronic (MDT) Partners with Merit Medical to Distribute Innova - GuruFocus
Medtronic partners with Merit Medical to distribute back pain device - Investing.com
Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain - PR Newswire
Medtronic’s OmniaSecure defib lead nets another FDA approval - Medical Device Network
Medtronic plc declares $0.71 dividend - MSN
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic's (NYSE:MDT) Global Reach Shapes Healthcare Innovation Across The S&P 500 - Kalkine Media
Medtronic (MDT) Gains FDA Approval for Expanded Use of OmniaSecu - GuruFocus
Medtronic gets FDA nod for defibrillation lead in heart pacing - Investing.com
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing - Medtronic
Trend Recap: What is the dividend yield of Medtronic plcChart Signals & Trade Opportunity Analysis Reports - baoquankhu1.vn
Stop Loss: Is Medtronic plc a top pick in the sectorJobs Report & Low Risk Investment Opportunities - baoquankhu1.vn
Medtronic (NYSE:MDT) Strengthens Neurovascular Portfolio And Russell 1000 Market Appeal - Kalkine Media
Medtronic Plc Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 - The Motley Fool
Medtronic (MDT) down 11.5% since last earnings report: Can it rebound? - MSN
FDA Clears MiniMed Flex Pump As Medtronic Valuation Debate Continues - Yahoo Finance
Medtronic (MDT) Down 11.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance Australia
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
MiniMed gets FDA nod for smaller insulin pump - MedTech Dive
Medtronic Named One of the 2026 World’s Most Ethical Companies® - CSRwire
PFA startup Field Medical appoints Mark Turco as CEO - MedTech Dive
Kimelman & Baird LLC Buys 29,978 Shares of Medtronic PLC $MDT - MarketBeat
Danske Bank A S Invests $71.89 Million in Medtronic PLC $MDT - MarketBeat
14,290 Shares in Medtronic PLC $MDT Purchased by Stance Capital LLC - MarketBeat
Medtronic (MDT) strengthens neurovascular platform with Scientia Vascular purchase - MSN
Medtronic (MDT) Strengthens Neurovascular Platform with Scientia Vascular Purchase - Insider Monkey
MDT PE Ratio & Valuation, Is MDT Overvalued - Intellectia AI
Medtronic PLC $MDT Stock Holdings Trimmed by Mairs & Power Inc. - MarketBeat
Medtronic: Snatch Up This Dividend Aristocrat Bargain Now (NYSE:MDT) - Seeking Alpha
Lighthouse Investment Partners LLC Has $4.92 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Gotham Asset Management LLC - MarketBeat
Medtronic plc Stock (ISIN: IE00BTN1Y115) Gains on MiniMed IPO Momentum and Neurovascular Acquisition - AD HOC NEWS
Smart Hospitals Market Is Booming So Rapidly | Medtronic Plc, Koninklijke Philips N.V., and GE Healthcare - openPR.com
Medtronic Seeks To Ax 'Extreme Outlier' $382M Antitrust Loss - Law360
Medtronic : leaders to speak on artificial intelligence and digital twin technology at upcoming NVIDIA GTC - marketscreener.com
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.39%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):